Product Description
CJC-1295 with DAC (Drug Affinity Complex) is a modified GHRH analog designed for extended duration growth hormone research applications.
Manufactured to pharmaceutical standards with 99%+ purity, this long-acting formulation provides sustained growth hormone elevation ideal for chronic research protocols.
The DAC modification extends the peptide's half-life significantly, making it valuable for researchers investigating sustained growth hormone effects and long-term metabolic changes in research models.
Specifications
Purity:99%+
Methodology:HPLC
Storage:2-8°C
Form:Lyophilized Powder
Features
- Long-acting GHRH
- DAC modification
- Extended duration
- Chronic protocols
Research Areas
Growth HormoneLong-term StudiesMetabolic ResearchEndocrine Function